CORCEPT THERAPEUTICS INC Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CORCEPT THERAPEUTICS INC treasury stock, shares, acquired for the quarter ending 2022-03-31 was 21.60M shares, a 1.41% increase year-over-year.
- CORCEPT THERAPEUTICS INC treasury stock, shares, acquired for the quarter ending 2021-03-31 was 21.30M shares, a 309.62% increase year-over-year.
- CORCEPT THERAPEUTICS INC treasury stock, shares, acquired for the quarter ending 2020-03-31 was 5.20M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2022-03-31 | 21.60M shares 10-Q · filed 2022-05-05 | |
| 2021-03-31 | 21.30M shares 10-Q · filed 2022-05-05 | |
| 2020-03-31 | 5.20M shares 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |